Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2009 Aug;124(2):461-468.
doi: 10.1097/PRS.0b013e3181adcf6a.

A placebo-controlled surgical trial of the treatment of migraine headaches

Bahman Guyuron  1 , Deborah Reed, Jennifer S Kriegler, Janine Davis, Nazly Pashmini, Saeid Amini
Affiliations
Randomized Controlled Trial

A placebo-controlled surgical trial of the treatment of migraine headaches

Bahman Guyuron et al. Plast Reconstr Surg. 2009 Aug.

Abstract

Background: Many of the nearly 30 million Americans suffering with migraine headaches are not helped by standard therapies, a proportion of which can harbor undesirable side effects. The present study demonstrates the efficacy of independent surgical deactivation of three common migraine headache trigger sites through a double-blind, sham surgery, controlled clinical trial.

Methods: Seventy-five patients with moderate to severe migraine headache who met International Classification of Headache Disorders II criteria were studied. Trigger sites were identified (frontal, temporal, and occipital), and patients were randomly assigned to receive either actual or sham surgery in their predominant trigger site. Patients completed the Migraine Disability Assessment, Migraine-Specific Quality of Life, and Medical Outcomes Study 36-Item Short Form Health Survey health questionnaires before treatment and at 1-year follow-up.

Results: Of the total group of 75 patients, 15 of 26 in the sham surgery group (57.7 percent) and 41 of 49 in the actual surgery group (83.7 percent) experienced at least 50 percent reduction in migraine headache (p < 0.05). Furthermore, 28 of 49 patients in the actual surgery group (57.1 percent) reported complete elimination of migraine headache, compared with only one of 26 patients in the sham surgery group (3.8 percent) (p < 0.001). Compared with the control group, the actual surgery group demonstrated statistically significant improvements in all validated migraine headache measurements at 1 year. These improvements were not dependent on the trigger site. The most common surgical complication was slight hollowing of the temple in the group with temporal migraine headache.

Conclusion: This study confirms that surgical deactivation of peripheral migraine headache trigger sites is an effective alternative treatment for patients who suffer from frequent moderate to severe migraine headaches that are difficult to manage with standard protocols.

PubMed Disclaimer

Comment in

References

    1. Lipton RB, Bigal ME, Diamond M, et al. Migraine prevalence, disease burden, and the need for preventive therapy. Neurology 2007;68:343–349.
    1. Lipton RB, Steward WF, Diamond S, Diamond ML, Reed M. Prevalence and burden of migraine in the United States: Data from the American Migraine Study II. Headache 2001;41:646–657.
    1. Stewart WF, Shechter A, Rasmussen BK. Migraine prevalence: A review of population-based studies. Neurology 1994;44(Suppl 4):S17–S23.
    1. Rozen TD. Migraine prevention: What patients want from medication and their physicians (a headache specialty clinic perspective). Headache 2006;46:750–753.
    1. Young WB, Hopkins MM, Shechter AL, Silberstein SD. Topiramate: A case series study in migraine prophylaxis. Cephalalgia 2002;22:659–663.

Publication types

Substances